Akebia Therapeutics Inc. buy Leerink Partnrs
Start price
30.04.25
/
50%
€2.11
Target price
30.04.26
-
Performance (%)
-44.00%
End price
01.05.26
€1.18
Summary
This prediction ended on 01.05.26 with a price of €1.18. Massive losses of -44.00% were the result for the BUY prediction by Leerink_Partnrs. Leerink_Partnrs has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Akebia Therapeutics Inc. | -0.266% | -0.266% | -71.776% |
| iShares Core DAX® | -1.586% | 5.028% | 6.332% |
| iShares Nasdaq 100 | -4.148% | -0.125% | 25.735% |
| iShares Nikkei 225® | -6.302% | 0.528% | 41.384% |
| iShares S&P 500 | -3.225% | 0.470% | 20.449% |
Comments by Leerink_Partnrs for this prediction
In the thread Akebia Therapeutics Inc. diskutieren
Akebia Therapeutics, Inc. (NASDAQ: AKBA) was upgraded by analysts at Leerink Partnrs to a "strong-buy" rating.
Ratings data for AKBA provided by MarketBeat
In the thread Trading Akebia Therapeutics Inc.
Die von Leerink_Partnrs gewählte maximale Laufzeit wurde überschritten